Collateral disease research and translational
medicine
Zhen-hua JIA
【期刊名称】《中国药理学与毒理学杂志》 【年(卷),期】2017(031)010
【摘要】Translational medicine, a kind of medical scientific practice oriented by patients'demands, emphasizes that basic theoretical study helps enhance clinical effect, transform into new drugs as well as meet major needs of social development and human health. It follows disciplinary development rules of TCM, persists in five-in-one (theory-clinic-new drug-experiment-evidence based) innovative new mode of TCM translational development, accelerates internal transformation of research findings, and promotes clinical effect and disciplinary development driven by the oretical innovation of collateral disease. In terms of the oretical research, establishment of new discipline of TCM collateral disease theory has become a practitioner and typical representative for promotion of TCM industry development. Important position and guiding role of theoretical innovation in disciplinary development has been valued. Systematically constructing ″collateral disease treatment based on syndrome differen?tiation″ and ″meridian-collateral theory″ lay a theoretical foundation for establishment of the discipline. With regard to clinical research, under the guidance of TCM
theory-collateral disease theory, systematic researches on Chinese medical pathogenesis, intervention strategy and effective formula of major diseases are conducted; series of innovative Chinese medicines are developed. Through pharmacody?namics study, relevant action mechanisms are investigated and revealed in- depth. Evidence- based medical researches prove that representative activating-collateral drugs developed under guidance of collateral disease theory have great application values in prevention and treatment of major refractory diseases such as ischemic cardio-cerebrovascular disease, arrhythmia, chronic heart failure, influenza, tumors and diabetes, bringing about significant economic and social benefits. In this way, international cooperation is promoted and internationalization process of innovative Chinese medicine is accelerated. USA FDA phase-Ⅱ clinical research of Lianhua Qingwen Capsules has been successfully launched. Guided by inheritance and innovation of conventional theory of TCM, the new five- in- one mode of development is established. Such a mode conforms to disciplinary development rules of TCM, suffi?ciently exerts core driving effect of TCM theory, realizes combination of theoretical innovation with clinical practice, specialty construction with disciplinary development and clinical research with original new drug, as well as powerfully promotes progress of TCM collateral disease discipline. 【总页数】1页(948)
【关键词】
【作者】Zhen-hua JIA
【作者单位】Hebei Yiling Hospital, Yiling 050091, China 【正文语种】英文 【中图分类】 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-pharmacology-toxicology_thesis/0201242152270.html 【相关文献】
1.Discussion about the Prognoses of Wilson＇s Disease with Severe Cortex Structure Impairment--A Case Report of Wilson＇s Disease （WD） Treated by the Traditional Chinese Medicine and Western Medicine [J], Songlin Chen; Yingyin Liang; Xiangxue Zhou; Xunhua Li
2.Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine： Diseases in External Medicine （Part 1） [J], Zhao-guo Li; Jian.ming Tan
3.Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine： Diseases in External Medicine （Part 2） [J], Zhao-guo Li
4.Comparative study on WHO Western Pacific Region and World
Federation of Chinese Medicine Societies international standard terminologies on traditional medicine： Diseases in External Medicine （Part 3） [J], Zhao-guo Li
5.Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine： Diseases in External Medicine （Part 4） [J], Zhao-guo Li
以上内容为文献基本信息，获取文献全文请下载
Collateral disease research and translational medicine
